Download PDF
Original Article  |  Open Access  |  17 Aug 2023

Preferential sugar utilization by bifidobacterial species

Views: 510 |  Downloads: 85 |  Cited:   0
Microbiome Res Rep 2023;2:31.
10.20517/mrr.2023.19 |  © The Author(s) 2023.
Author Information
Article Notes
Cite This Article

Abstract

Aim: Bifidobacteria benefit host health and homeostasis by breaking down diet- and host-derived carbohydrates to produce organic acids in the intestine. However, the sugar utilization preference of bifidobacterial species is poorly understood. Thus, this study aimed to investigate the sugar utilization preference (i.e., glucose or lactose) of various bifidobacterial species.

Methods: Strains belonging to 40 bifidobacterial species/subspecies were cultured on a modified MRS medium supplemented with glucose and/or lactose, and their preferential sugar utilization was assessed using high-performance thin-layer chromatography. Comparative genomic analysis was conducted with a focus on genes involved in lactose and glucose uptake and genes encoding for carbohydrate-active enzymes.

Results: Strains that preferentially utilized glucose or lactose were identified. Almost all the lactose-preferring strains harbored the lactose symporter lacS gene. However, the comparative genomic analysis could not explain all their differences in sugar utilization preference. Analysis based on isolate source revealed that all 10 strains isolated from humans preferentially utilized lactose, whereas all four strains isolated from insects preferentially utilized glucose. In addition, bifidobacterial species isolated from hosts whose milk contained higher lactose amounts preferentially utilized lactose. Lactose was also detected in the feces of human infants, suggesting that lactose serves as a carbon source not only for infants but also for gut microbes in vivo.

Conclusion: The different sugar preference phenotypes of Bifidobacterium species may be ascribed to the residential environment affected by the dietary habits of their host. This study is the first to systematically evaluate the sugar uptake preference of various bifidobacterial species.

Keywords

Bifidobacterium, preferential utilization, carbon source, human-residential bifidobacteria, lactose

INTRODUCTION

Bifidobacteria are anaerobic gram-positive bacteria that inhabit the digestive tracts of humans and other animals[1-3]. This genus is highly diverse and comprises more than 110 taxa with strong host specificity in their habitats. This specificity is thought to result from their adaptive and evolutionary fitness in diverse environments, including the intestinal tract of their hosts. For instance, some bifidobacterial species that colonize the human infant gut preferentially degrade human milk oligosaccharides (HMOs)[4,5], whereas those that colonize the adult intestine preferentially utilize complex polysaccharides, such as plant-derived dietary fiber[6-8]. Additionally, some studies have reported that bifidobacterial strains isolated from the guts of insects have a metabolic pathway for assimilating trehalose, a sugar present in insects, including honeybees, and in plants and fungi[9,10].

Microbial adaptation to the host diet has been reported in several species, including Lactiplantibacillus plantarum, Bacteroides thetaiotaomicron, and Bifidobacterium[11,12]. Phocaeicola plebeius, which has an enzyme that degrades seaweed-derived polysaccharides, inhabits the gut of Japanese people who have a long history of consuming seaweed but not the gut of North American people who have no such history[13]. Adaptation to the host diet, the primary source of essential nutrients for microbial growth, may be considered a survival strategy for gut microbes to outcompete other bacteria in the intestine where nutrient sources are limited.

In environments with multiple saccharides, bacteria can either co-metabolize different carbon sources or preferentially utilize specific compounds to optimize and fine-tune energy metabolism. This preference is referred to as carbon catabolite repression (CCR), which was first described as a diauxie phenomenon in Escherichia coli by Monod et al.[14]. The bacterium imports glucose first before lactose when both sugars are present in the medium. The CCR mechanism was initially attributed to transcriptional regulation mediated by the cyclic AMP receptor protein[15] but is now linked to glucose uptake via the phosphoenolpyruvate:sugar phosphotransferase system, which effectively excludes other saccharides from being imported[16,17]. In general, glucose is preferentially utilized by bacteria, including Bacillus subtilis and Staphylococcus aureus[18]. Conversely, some bacteria exhibit a reverse CCR mechanism, preferring alternative carbon sources over glucose[19]. For instance, the soil-dwelling bacterium Pseudomonas preferentially utilizes organic acids, which are abundant in its habitat, over glucose. Bifidobacterium longum, which is frequently found in infant feces, has a unique preference for lactose over glucose[20,21]. These studies indicate that sugar preferences vary among bacterial species. However, the sugar utilization preference of bifidobacterial species is poorly understood.

In this study, we aimed to systematically analyze the sugar preferences of bifidobacterial species using glucose and lactose as substrates. Then, we used comparative genomic approaches to elucidate the molecular mechanisms underlying species-dependent carbohydrate preferences. Although we failed to identify the genetic traits responsible for this preference, this systematic study provides novel insights into how different species belonging to the same genus adapt differently to the host environment.

METHODS

Bacterial strains and media

Eighty-one bifidobacterial strains were purchased from the Riken BioResource Research Center (JCM, Tsukuba, Japan), American Type Culture Collection (ATCC), and German Collection of Microorganisms and Cell Cultures (DSMZ) and used to inoculate MRS medium (Becton Dickinson and Company). After several passages, 40 strains that showed substantial growth in the medium were selected for this study, considering their taxonomic variety. Furthermore, five commercial strains of Bifidobacterium longum, Bifidobacterium bifidum, and Bifidobacterium breve were included. In total, 45 strains of bifidobacteria were used for sugar consumption analyses. Their scientific names, strain numbers, and isolation sources are listed in Table 1.

Table 1

List of strains used in this study

NumberStrainPhylogenomic groupOriginClassification
1B. psychraerophilum JCM 15958B. psychraerophilumPorcine cecumPig
2B. asteroides JCM 8230B. asteroidesHindgut of honeybeeBee
3B. coryneforme JCM 5819B. asteroidesHindgut of honeybee Apis mellifera caucasicaBee
4B. callimiconis JCM 33352B. tissieriStool sample of a Goeldi’s marmoset (Callimico goeldii)Marmoset
5B. simiarum JCM 31793B. tissieriFeces of an adult emperor tamarin (Saguinus imperator)Tamarin
6B. tissieri JCM 30798B. tissieriFeces of a common marmosetsMarmoset
7B. avesanii JCM 30943Not categorized 1Feces of an adult subject of the cotton-top tamarinTamarin
8B. boum ATCC 27917B. boumRumen of cattleOthers
9B. porcinum JCM 16945B. boumPiglet fecesPig
10B. thermacidophilum ssp. thermacidophilum JCM 11165B. boumWastewater of a bean-curd farmOthers
11B. thermophilum ATCC 25525B. boumSwine fecesPig
12B. mongoliense JCM 15461Not categorized 2Airag, a traditional fermented mare’s milk product from MongoliaOthers
13B. subtile ATCC 27537Not categorized 2SewageSewage
14B. aemilianum JCM 33373B. bombiGut samples of carpenter bees (Xylocopa violacea)Bee
15B. bohemicum JCM 18049B. bombiDigestive tract contents of a bumblebee (Bombus lucorum)Bee
16B. minimum JCM 5821Not categorized 3SewageSewage
17B. tsurumiense JCM 13495Not categorized 3Dental plaque from hamster fed with a high-carbohydrate dietOthers
18B. breve JCM 1192B. longumIntestine of infantHuman
19B. breve MCC1274B. longumIntestine of infantHuman
20B. breve MCC1851B. longumIntestine of infantHuman
21B. felsineum JCM 31789B. longumFeces of an adult subject of the cotton-top tamarin (Saguinus oedipus)Tamarin
22B. longum ssp. infantis ATCC 15697B. longumIntestine of infantHuman
23B. longum ssp. infantis MCC1872B. longumIntestine of infantHuman
24B. longum ssp. longum JCM 1217B. longumIntestine of adultHuman
25B. longum ssp. longum MCC5360B. longumIntestine of infantHuman
26B. parmae JCM 32706B. longumStool sample of a pygmy marmoset (Callithrix pygmaea)Marmoset
27B. reuteri JCM 17295B. longumFeces of a common marmosetMarmoset
28B. saguini JCM 17297B. longumFeces of a red-handed tamarinTamarin
29B. stellenboschense JCM 17298B. longumFeces of a red-handed tamarinTamarin
30B. aerophilum JCM 30941B. bifidumFeces of an adult subject of the cotton-top tamarinTamarin
31B. biavatii JCM 17299B. bifidumFeces of a red-handed tamarinTamarin
32B. bifidum MCC2030B. bifidumIntestine of infantHuman
33B. hapali JCM 30799B. bifidumFeces of a common marmosetsMarmoset
34B. ramosum JCM 30944B. bifidumFeces of an adult subject of the cotton-top tamarinTamarin
35B. adolescentis JCM 1275B. adolescentisIntestine of adultHuman
36B. dentium DSMZ20436B. adolescentisDental cariesHuman
37B. pseudocatenulatum JCM 1200B. adolescentisFeces of an infantHuman
38B. pullorum ssp. gallinarum JCM 6291B. pullorumChicken cecumBird
39B. pullorum ssp. saeculare JCM 8223B. pullorumRabbit fecesOthers
40B. animalis ssp. animalis ATCC 25527B. pseudolongumRat fecesOthers
41B. animalis ssp. lactis DSMZ10140B. pseudolongumYogurtOthers
42B. anseris JCM 32705B. pseudolongumStool sample of a domestic goose (Anser domesticus)Bird
43B. choerinum ATCC 27686B. pseudolongumSwine fecesPig
44B. choloepi JCM 34854B. pseudolongumFeces of an adult subject of the two-toed slothOthers
45B. pseudolongum ssp. pseudolongum JCM 1205B. pseudolongumSwine fecesPig

Bacterial culture

Preferential utilization of glucose or lactose was assessed as previously described[20]. Modified MRS medium [1% w/v proteose peptone #3, 1% w/v beef extract, 0.5% w/v yeast extract (all from Becton Dickinson and Company Franklin Lakes, NJ, USA), 0.1% v/v Tween 20 (Nacalai Tesque Inc., Tokyo, Japan), 0.5% w/v K2HPO4 (Kokusan Chemical Co., Tokyo, Japan), and 0.5% w/v sodium acetate, 0.5% w/v di-ammonium hydrogen citrate, 0.02% w/v MgSO4·7H2O, and 0.005% MnSO4·H2O (all from Fujifilm Wako Pure Chemical Corporation, Tokyo, Japan), pH 6.5] was used for cultivation. The medium was supplemented with 0.8% (w/v) glucose (MRS-G), 0.8% lactose (MRS-L), or a mixture of 0.4% glucose and 0.4% lactose (MRS-GL) [Supplementary Table 1] prior to inoculation. We employed these sugar concentrations for determining the sugar preference of each strain because we found that these concentrations enable us to visually monitor the sugar consumption by high-performance thin-layer chromatography (HPTLC) analysis (see below).

Bacteria were pre-cultured in MRS medium at 37 °C for 24 h under anaerobic conditions, and then the cultures (400 µL per each) were centrifuged at 2,000 g for 3 min. The resulting pellets were washed twice with a saline solution (Otsuka Pharmaceutical, Tokyo, Japan), and 75 µL of each of the 400 µL suspensions was used to inoculate 2.5 mL of MRS-GL, MRS-G, or MRS-L medium supplemented with 0.05% (w/v) L-cysteine HCl (Kanto Chemical, Tokyo, Japan) in a 5 mL tube (Sarstedt, Nuembrecht, Germany). The culture broth was incubated at 37 °C for 72 h under anaerobic conditions (in N2:H2:CO2, 80:10:10). Aliquots (0.2 mL per each) were taken and the optical densities at 600 nm (OD600) were measured using a multi-microplate reader (SH-9000Lab, Hitachi, Tokyo, Japan). The cultures were centrifuged, and the resulting supernatants were used for high-performance thin-layer chromatography (HPTLC).

HPTLC analysis

Pre-coated silica gel-60 HPTLC aluminum plates (Merck, Darmstadt, Germany) were used to evaluate the sugar preferences of the bifidobacterial strains. The culture supernatants (0.5 µL per each) were loaded on the plate. The spotted plate was developed in a solvent system consisting of 1-butanol (Nacalai Tesque):acetic acid (Kanto Chemical):water (2:1:1 v/v). The plates were stained by spraying with diphenylamine-aniline-phosphoric acid reagent as previously described[22] , and the sugars were visualized by baking the plates for 2 min.

Comparative genomic analysis

Genomic information of the type strains of the 40 Bifidobacterium species was retrieved from the NCBI public database [Supplementary Table 1]. Given its preference for lactose over glucose by repressing the glucose transporter glcP in the presence of lactose in the medium[20], B. longum NCC2705 was also included in this in silico analysis as the strain has been shown to exhibit a preference for lactose over glucose by repressing the glucose transporter glcP in the presence of lactose in the medium[20]. Amino acid sequence comparisons were performed using all-against-all bidirectional BLAST alignment (cut-off: E-value 0.0001, with at least 50% identity across at least 50% of either protein sequence). The sequences were then clustered into protein families by using the Markov clustering algorithm (MCL) implemented in the mclblastline pipeline v12-0678[23]. An example of the scripts used for the analysis is available at https://github.com/frbot/Comparative-genomics/blob/master/comparative.sh. The upstream sequence of glcP was aligned using the ClustalW alignment tool[24] with default parameters. The carbohydrate-active enzymes were annotated using the dbCAN3 server (https://bcb.unl.edu/dbCAN2/) and the HMMER: dbCAN tool (E-Value < 1e-15, coverage > 0.35). Intergroup differences were analyzed using Welch’s t-test, followed by Benjamini-Hochberg FDR calculations on R software (ver. 3.6.0) with the qvalue package (http://www.bioconductor.org/packages/release/bioc/html/qvalue.html).

Fecal sample collection

Fecal samples of 10 infants at 2, 4, 6, and 8 weeks of age were collected from their diapers by their parents as soon as possible after defecation. The samples were stored at -20 °C at home until all samples from each subject were collected. The samples were then transported to the laboratory at less than -18 °C by logistics companies. Upon receipt, the samples were immediately stored at -80 °C until use. This study was approved by the institutional review board of the Japan Conference of Clinical Research (approval number: BONYU-01) and was conducted in accordance with the latest Declaration of Helsinki in 2013. Healthy mothers of the infants provided written informed consent for their participation in all procedures associated with the study.

Determination of lactose content in infant fecal samples

Lactose in the fecal samples was fluorescently labeled and quantified using high-performance liquid chromatography (HPLC). Specifically, the lyophilized fecal samples (3-5 mg) were rehydrated with 5% acetic acid (100 μL), fragmented in an ultrasonic bath for 10 min, and then mixed with a solution containing 120 µL of chloroform (Nacalai Tesque Inc.), 240 µL of methanol (Nacalai Tesque Inc.), and 20 µL of 10 mM melibiose (Fujifilm Wako Pure Chemical Corporation). Melibiose was used as the internal standard. After further mixing with 120 µL of chloroform and 120 µL of pure water (Milli-q), the supernatant obtained by centrifugation (21,500 g, 3 min, 4 ºC) was lyophilized after evaporation of methanol. The saccharides were then fluorescently labeled with 2-anthranilic acid and purified by solid extraction using Discovery DPA-6S columns (50 mg) (Supelco, Poole, UK) following a previously described method[25]. HPLC was performed using a Thermo U3000 system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a TSKgel Amide-80 HR column (4.6 mm × 250 mm, φ = 5 μm) (Tosoh, Tokyo, Japan) as previously described[26]. The labeled sugars were detected using a Waters 2475 Fluorescence Detector (Waters Corp., Milford, MA, USA). Lactose concentrations were calculated using known concentrations of standard lactose and normalized to the internal standard melibiose.

RESULTS

Preferential utilization of glucose or lactose by each bifidobacterial strain

The ability of each Bifidobacterium strain to grow in the MRS-G and MRS-L media was evaluated [Figure 1]. Although most strains were able to utilize both glucose and lactose, the strains of B. asteroides (#2, the numbers are indicated in Table 1 and Figures 1 and 2), B. boum (#8), B. thermophilum (#11), B. pullorum subsp. gallinarum (#38), and B. pullorum subsp. saeculare (#39) showed limited growth on a lactose-containing medium (OD600 < 0.1). In general, the strains of B. boum group and B. pollurum group showed poor lactose utilization. The preferential carbon utilization of each strain was then evaluated by incubating the strains in a medium containing both glucose and lactose and analyzing their sugar consumption behavior through HPTLC [Supplementary Figures 1 and 2]. The results definitively differentiated lactose- and glucose-preferring strains. Based on the phylogenomic tree of the genus Bifidobacterium reported by Lugli et al., we found that the B. asteroides, B. boum, B. bombi, and B. pullorum groups preferentially utilized glucose, whereas B. tissieri and B. adolescentis groups preferentially utilized lactose[27]. The B. longum, B. bifidum, and B. pseudolongum groups contained glucose- and lactose-preferring strains. Evaluations were also conducted using commercialized strains belonging to three taxa: B. breve (#19 and 20), B. longum subsp. longum (#25), and B. longum subsp. infantis (#23), with no differences in sugar preference observed within the species or subspecies.

Preferential sugar utilization by bifidobacterial species

Figure 1. Saccharide utilization preferences and the ability of each Bifidobacterium strain to grow on each carbon source. Strains are sorted based on concatenation of 101 core protein sequences of the genus Bifidobacterium as previously reported. Numbering of each strain corresponds to Table 1.

Distribution of genes involved in lactose and glucose uptake among bifidobacterium species

The distribution of the lactose symporter gene lacS[28] was examined to explore the genetic basis of preferential sugar utilization by bifidobacteria. All of the strains that showed a preference for lactose over glucose had a lacS homolog with amino acid identities higher than 50%, except for B. choerinum ATCC 27686 (#43) [Supplementary Table 2]. The exceptional strain B. choerinum ATCC 27686 (#43), whose genomic sequence was complete, showed the lowest growth rate in the medium supplemented with glucose. A lacS homolog search also revealed that not all strains with a lacS homolog preferentially utilized lactose. For example, B. reuteri JCM 17295 (#27) and B. pseudolongum ssp. pseudolongum JCM 1205 (#45) preferred glucose over lactose. Next, we investigated the homolog distribution of the glcP, ptsG, and licT gene cluster (BL1631, BL1632, and BL1633 in B. longum NCC2705), which are reportedly involved in the preferential utilization of lactose in NCC2705[20]. Of the 40 isolates, 12 strains had all three homologs, and six had three genes within the same cluster. However, we found no correlation between the presence of these genes and the preferential utilization of lactose [Supplementary Table 2]. DNA sequence alignment was conducted for the regulatory regions of glcP, which comprise a potential rho-independent terminator and a ribonucleic anti-terminator (RAT) element, to identify differences that could explain the variability in the preferential utilization of sugars. However, no distinguishing features were detected [Supplementary Figure 3]. Gene-trait matching based on MCL clustering did not reveal any corresponding gene family [Supplementary Table 3]. We also examined the distribution of glycosyl hydrolases using dbCAN; however, no clear relationship was detected between the preferential sugar utilization phenotype and the presence of these enzymes [Supplementary Table 4].

Link between sugar preference by bifidobacterial strains and their isolation source

The relationship between the origin of the bifidobacterial isolates and their sugar preferences was investigated by sorting them based on their source [Figure 2, Supplementary Figures 1 and 2]. All human-derived bifidobacterial strains belonging to seven species/subspecies demonstrated a preference for lactose, whereas all strains isolated from bees and sewage exhibited a preference for glucose. The other bifidobacterial strains isolated from different sources showed varied preferences for glucose and lactose; however, four of the five strains isolated from marmosets preferred lactose. In addition, B. animalis ssp. lactis (#41) and B. mongoliense (#12) isolated from yogurt and horse milk wine, respectively, preferentially utilized lactose.

Preferential sugar utilization by bifidobacterial species

Figure 2. Preference of glucose and lactose utilization and the ability of each Bifidobacterium strain to grow on each carbon source. Strains are sorted based on their isolation source.

Relationship between lactose content in host milk and lactose-preferring bifidobacterial strains

Considering that B. animalis ssp. lactis and B. mongoliense are commonly found in lactose-rich environments, we hypothesized that the lactose content in the milk of their host animals is associated with their preference for lactose utilization. A literature search was conducted to obtain data on the lactose content in mammalian milk [Table 2]. The lactose concentration in the breast milk of humans and marmosets was relatively higher (≥ 75 g/L) than that in the milk of other animals (< 75 g/L), and most strains isolated from humans and marmosets showed a relatively strong preference for lactose [Figure 2 and Supplementary Figure 4].

Table 2

Lactose concentrations in host animals’ milk, as obtained from published studies

AnimalLactose (g/L)Sample numberRef.
Human78 ± 8.8273[29]
79.2 ± 11412[30]
Marmoset75-[31]
78 (reared), 80 (wild)-[32]
80-[33]
Tamarin72-[34]
Pig48-[35]
4518[36]
55-[37]
Rat11 ± 0.23 - 33 ± 1.8227[38]
26-[37]
Hamster49-[37]
Cow36.1 ± 1310[39]
Rabbit19, 14-26-[40]

Lactose contents in the fecal samples of breastfed infants

Finally, to infer the lactose availability in the gut microbial ecosystem of human infants, lactose concentrations were determined in fecal samples obtained from 10 breastfed infants at 2, 4, 6, and 8 weeks of age. Lactose was detected in 37 out of 40 samples, with median concentrations of 0.47, 0.42, 0.29, and 0.22 mg/g feces at the respective time points [Figure 3].

Preferential sugar utilization by bifidobacterial species

Figure 3. Lactose concentration in fecal samples collected from 10 breastfed infants at 2, 4, 6, and 8 weeks of age. (A) Boxplots of lactose concentrations. Medians with interquartile range are shown. The whiskers represent quartile range; (B) Changes in fecal lactose concentrations in individuals over 6 weeks.

Upper heatmap displays the optical density (OD600nm) values of Bifidobacterium cultures in MRS medium supplemented with 0.8% w/v glucose or lactose. Lower heatmap shows the OD600nm values of Bifidobacterium cultures in MRS medium supplemented with a mixture of 0.4% w/v glucose and 0.4% w/v lactose. Colored bars indicate the phylogenetic group to which each strain belongs. Black bars indicate the strains that were not classified into any group. Pie charts represent the ratios of glucose- (blue) and lactose-preferred (orange) strains within the respective taxonomic groups.

This figure is a reorganization of Figure 1 based on the isolation source rather than the phylogenetic group. The light gray bar indicates strains that were not classified into any group. The number of each strain is listed in Table 1.

DISCUSSION

Bifidobacteria play a crucial role in the human gut, particularly in breastfed infants, where they contribute to healthy development by producing short-chain fatty acids and tryptophan metabolites, such as indole-3-lactic acid[41,42]. In this study, we investigated the sugar utilization preference of 40 bifidobacterial species/subspecies that colonize diverse hosts, based on a previous finding that B. longum NCC2705 preferentially metabolizes lactose over glucose[20]. The results of the in vitro assay demonstrated that the sugar preferences of the bifidobacterial species varied. Our results also suggested that sugar preference within the genus Bifidobacterium may be linked to the isolation source and phylogenetic status[27]. To the best of our knowledge, this study is the first to systematically evaluate the order of sugar uptake in various bifidobacterial species.

All human-residential bifidobacteria (HRB) strains preferentially utilize lactose. B. longum subsp. infantis, B. breve, B. bifidum, and B. longum, which are present in the infant gut, can utilize HMOs[25], and this feature has been linked to their dominance in the infant gut[5]. Although lactose is considerably more abundant than HMOs in breast milk, whether lactose would reach the large intestine is unclear, considering that it should be absorbed in the small intestine as an energy source for infants. In the present study, lactose was detected in the feces of all infants, indicating that lactose could also serve as an energy source for gut microbes, particularly for bacteria that preferentially metabolize lactose and have a competitive advantage in the gut of hosts consuming breast milk with high lactose content. The lactose concentration in the infant feces was higher at 2-4 weeks after birth than at 6 weeks. This result suggests that the lactose breakdown and absorption functions in infants are underdeveloped in the first month of life and that lactose in fecal samples is more abundant during this period. Lactose can be released from HMOs by extracellular lacto-N-biosidases[43,44], fucosidases[45,46], and sialidases[47], although the abundance and prevalence of these genes are not generally high in the infant gut microbiome[4]. Although the HRB species B. adolescentis and B. dentium preferentially utilized lactose over glucose, they were not frequently detected in the infant gut. However, B. adolescentis is assumed to have evolved over 15 million years in primates[48]. Therefore, we speculate that the characteristics acquired during coevolution may have been preserved within the HRB.

Our findings also suggest that bifidobacteria in the gut of breastfed infants utilize lactose, which remains undigested by lactase in the small intestine, in addition to metabolizing HMOs present in breast milk. HMOs in breast milk are present at high concentrations and have various complex chemical structures; thus, their metabolism by infant bifidobacteria may contribute to the formation of a complex, different species/strain-assembled community. Bifidobacteria isolated from the feces of marmosets with high milk carbohydrate concentrations appeared to retain their preferential utilization of lactose. Although the ratio of lactose to milk oligosaccharides in marmoset milk has not been reported, the predominance of lactose in the milk of other New World monkeys, such as capuchin (tufted capuchin), howler (mantled howler), and squirrel monkey (Bolivian squirrel monkey)[49], suggests that marmoset milk contains a high concentration of lactose and a low ratio of milk oligosaccharides. Therefore, bifidobacteria in the intestinal tract of marmosets are expected to grow primarily on lactose rather than on milk oligosaccharides. Bifidobacteria residing in lactating primates possibly first evolved to preferentially assimilate lactose, which is undigested in the small intestine and reaches the large intestine, and then further adapted to the environment in the human gastrointestinal tract by acquiring the ability to metabolize the various chemical structures of HMOs. However, further research is warranted to understand how most bifidobacteria in marmosets differ from those in tamarins, which preferentially utilize glucose rather than lactose.

Four bifidobacterial species isolated from insects preferentially utilized glucose. B. asteroides, which effectively metabolizes both glucose and fructose[50], was unable to utilize lactose. B. animalis ssp. lactis and B. mongoliense preferentially utilized lactose and were isolated from fermented cow’s milk and mare’s milk liquor, respectively, both of which contain high levels of lactose in dairy products. These results imply that gene acquisition and loss and/or the CCR system in bifidobacteria are adaptations to their natural habitats.

Searches for genes and gene clusters were conducted to elucidate the mechanisms underlying preferential lactose utilization. Almost all the strains preferentially utilizing lactose harbored a lacS homolog [Supplementary Table 2]. However, not all strains with a lacS homolog preferentially utilized lactose, and several strains that grew in the lactose-containing medium did not harbor a lacS homolog, such as B. coryneforme JCM 5819 (#3) and B. aemilianum JCM 33373 (#14). Studies have also focused on glycosyl hydrolases, homologs of the glcP, ptsG, and licT gene cluster, and the regulatory regions of glcP, which are reportedly involved in the preferential utilization of lactose in B. longum NCC2705. However, the results did not reveal any significant genetic traits that could differentiate sugar preference phenotypes. These results suggest that the genetic basis underlying the preference of bifidobacteria for utilizing sugars is complex and possibly involves additional genetic factors that were not examined in this study or have not yet been identified. Some bifidobacterial strains may possess unidentified lactose or glucose transporter(s). For example, B. choerinum ATCC 27686 (#43), which showed a preference for lactose over glucose but did not harbor the lacS homolog, possesses genes encoding one GH1, two GH2, and two GH42 enzymes that potentially have b-galactosidase activity [Supplementary Table 4]. However, none of the homologs possessed signal sequences at their N-termini. Therefore, this bacterium may possess an unidentified lactose transporter. RNA sequencing analysis and subsequent gene knockout studies using newly developed methods[6,51] are necessary to comprehensively understand the general or species-specific CCR system in the genus Bifidobacterium.

This study has some limitations. For instance, the results cannot be generalized to all bifidobacterial species because the evaluation was performed using only strains that grew well in MRS. In addition, in most cases, only type strains were selected for evaluation. Therefore, our results should be interpreted carefully, i.e., whether they are specific to the species or to a certain strain of the species. Furthermore, although trends in sugar preference were observed in accordance with the source of isolation, some results did not align with our hypotheses. For instance, B. anseris JCM 32705 (#40) originates from birds and preferentially utilizes lactose. However, birds are not known to consume lactose. The gut microbiota composition is influenced by microbes in the environment[52]; therefore, the isolation source does not necessarily reflect the original habitat of the strains. Thus, careful interpretation is necessary to understand how environmental factors affect sugar preferences and adaptation strategies for specific bifidobacterial species. Another limitation of this study is that it did not explore the sugar utilization preference of gut bacteria other than Bifidobacterium. Given this competitive environment, the extent to which undigested lactose contributes to bifidobacterial growth in the infant gut remains unclear. From this perspective, further research examining how microbial sugar utilization preferences are regulated and how these preferences contribute to gut microbiota dynamics is warranted.

In summary, the evaluation of the preferential utilization of glucose and/or lactose in Bifidobacterium species revealed that most bifidobacterial strains derived from hosts with high lactose content in their milk preferentially utilize lactose. These findings imply that lactose may partly contribute to shaping the early stages of gut microbiota formation and HRB community formation in the infant gut, along with their capacity to metabolize HMOs.

DECLARATIONS

Acknowledgments

We thank Kana Yamaguchi and Aya Mizuno for technical support. We would like to thank Editage (www.editage.jp) for English language editing. Graphical Abstract was created with BioRender.com.

Authors’ contributions

Conceived and designed the experiments: Murakami R, Odamaki T

Performed experiments to elucidate preferential sugar utilization: Murakami R

Analyzed lactose concentration in infant feces: Yoshida K, Sakanaka M

Analyzed the data: Murakami R, Odamaki T

Drafted the manuscript: Murakami R, Odamaki T

Edited the manuscript and supervised the study: Urashima T, Xiao JZ, Katayama T, Odamaki T

All authors discussed the data and contributed to completing the final manuscript.

Availability of data and materials

Not applicable.

Financial support and sponsorship

None.

Conflicts of interest

The employment of MS at Kyoto University was supported in part by the Morinaga Milk Industry Co., Ltd. The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this study.

Ethical approval and consent to participate

This study was approved by the institutional review board of the Japan Conference of Clinical Research (approval number: BONYU-01) and was conducted in accordance with the latest Declaration of Helsinki in 2013. Healthy mothers of newborn infants provided written informed consent for their participation in all procedures associated with the study.

Consent for publication

Not applicable.

Copyright

© The Author(s) 2023.

Supplementary Materials

REFERENCES

1. Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and their health-promoting effects. Microbiol Spectr 2017.

2. Wong CB, Odamaki T, Xiao JZ. Insights into the reason of human-residential bifidobacteria (HRB) being the natural inhabitants of the human gut and their potential health-promoting benefits. FEMS Microbiol Rev 2020;44:369-85.

3. Chichlowski M, Shah N, Wampler JL, Wu SS, Vanderhoof JA. Bifidobacterium longum subspecies infantis (B. infantis) in pediatric nutrition: current state of knowledge. Nutrients 2020;12:1581.

4. Sakanaka M, Gotoh A, Yoshida K, et al. Varied pathways of infant gut-associated bifidobacterium to assimilate human milk oligosaccharides: prevalence of the gene set and its correlation with bifidobacteria-rich microbiota formation. Nutrients 2019;12:71.

5. Sakanaka M, Hansen ME, Gotoh A, et al. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis. Sci Adv 2019;5:eaaw7696.

6. Katoh T, Yamada C, Wallace MD, et al. A bacterial sulfoglycosidase highlights mucin O-glycan breakdown in the gut ecosystem. Nat Chem Biol 2023;19:778-89.

7. Kan Z, Luo B, Cai J, Zhang Y, Tian F, Ni Y. Genotyping and plant-derived glycan utilization analysis of bifidobacterium strains from mother-infant pairs. BMC Microbiol 2020;20:277.

8. Kelly SM, Munoz-Munoz J, van Sinderen D. Plant glycan metabolism by bifidobacteria. Front Microbiol 2021;12:609418.

9. Wyatt GR. The biochemistry of sugars and polysaccharides in insects. Adv Insect Physiol 1967;4:287-360.

10. Milani C, Lugli GA, Duranti S, et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci Rep 2015;5:15782.

11. Martino ME, Joncour P, Leenay R, et al. Bacterial adaptation to the host’s diet is a key evolutionary force shaping drosophila-lactobacillus symbiosis. Cell Host Microbe 2018;24:109-19.e6.

12. Dapa T, Ramiro RS, Pedro MF, Gordo I, Xavier KB. Diet leaves a genetic signature in a keystone member of the gut microbiota. Cell Host Microbe 2022;30:183-99.e10.

13. Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-12.

14. Monod J. The phenomenon of enzymatic adaptation and its. bearings on problems of genetics and cellular differentiation. Growth 1947;2:223-89. Available from: https://eurekamag.com/research/013/889/013889555.php. [Last accessed on 17 Aug 2023]

15. Pastan I, Perlman R. Cyclic adenosine monophosphate in bacteria. Science 1970;169:339-44.

16. Inada T, Kimata K, Aiba H. Mechanism responsible for glucose-lactose diauxie in Escherichia coli: challenge to the cAMP model. Genes Cells 1996;1:293-301.

17. Wuttge S, Licht A, Timachi MH, Bordignon E, Schneider E. Mode of interaction of the signal-transducing protein EIIA(Glc) with the maltose ABC transporter in the process of inducer exclusion. Biochemistry 2016;55:5442-52.

18. Nair A, Sarma SJ. The impact of carbon and nitrogen catabolite repression in microorganisms. Microbiol Res 2021;251:126831.

19. Park H, McGill SL, Arnold AD, Carlson RP. Pseudomonad reverse carbon catabolite repression, interspecies metabolite exchange, and consortial division of labor. Cell Mol Life Sci 2020;77:395-413.

20. Parche S, Beleut M, Rezzonico E, et al. Lactose-over-glucose preference in bifidobacterium longum NCC2705: glcP, encoding a glucose transporter, is subject to lactose repression. J Bacteriol 2006;188:1260-5.

21. Kim TB, Song SH, Kang SC, Oh DK. Quantitative comparison of lactose and glucose utilization in bifidobacterium longum cultures. Biotechnol Prog 2003;19:672-5.

22. Murakami R, Hashikura N, Yoshida K, Xiao JZ, Odamaki T. Growth-promoting effect of alginate on faecalibacterium prausnitzii through cross-feeding with bacteroides. Food Res Int 2021;144:110326.

23. Enright AJ, Van Dongen S, Ouzounis CA. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 2002;30:1575-84.

24. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.

25. Asakuma S, Hatakeyama E, Urashima T, et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem 2011;286:34583-92.

26. Ojima MN, Jiang L, Arzamasov AA, et al. Priority effects shape the structure of infant-type bifidobacterium communities on human milk oligosaccharides. ISME J 2022;16:2265-79.

27. Lugli GA, Calvete-Torre I, Alessandri G, et al. Phylogenetic classification of ten novel species belonging to the genus Bifidobacterium comprising B. phasiani sp. nov., B. pongonis sp. nov., B. saguinibicoloris sp. nov., B. colobi sp. nov., B. simiiventris sp. nov., B. santillanense sp. nov., B. miconis sp. nov., B. amazonense sp. nov., B. pluvialisilvae sp. nov., and B. miconisargentati sp. nov. Syst Appl Microbiol 2021;44:126273.

28. Foucaud C, Poolman B. Lactose transport system of streptococcus thermophilus. Functional reconstitution of the protein and characterization of the kinetic mechanism of transport. J Biol Chem 1992;267:22087-94.

29. Wojcik KY, Rechtman DJ, Lee ML, Montoya A, Medo ET. Macronutrient analysis of a nationwide sample of donor breast milk. J Am Diet Assoc 2009;109:137-40.

30. Pace RM, Williams JE, Robertson B, et al. Variation in human milk composition is related to differences in milk and infant fecal microbial communities. Microorganisms 2021;9:1153.

31. Turton JA, Ford DJ, Bleby J, Hall BM, Whiting R. Composition of the milk of the common marmoset (Callithrix jacchus) and milk substitutes used in hand-rearing programmes, with special reference to fatty acids. Folia Primatol 1978;29:64-79.

32. Power ML, Oftedal OT, Tardif SD. Does the milk of Callitrichid monkeys differ from that of larger anthropoids? Am J Primatol 2002;56:117-27.

33. Osthoff G. Milk | Milks of non-dairy mammals. In: Encyclopedia of Dairy Sciences. Elsevier; 2011. p. 538-52. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780123744074003204. [Last accessed on 17 Aug 2023].

34. Power ML, Verona CE, Ruiz-Miranda C, Oftedal OT. The composition of milk from free-living common marmosets (Callithrix jacchus) in Brazil. Am J Primatol 2008;70:78-83.

35. Zhang S, Chen F, Zhang Y, et al. Recent progress of porcine milk components and mammary gland function. J Anim Sci Biotechnol 2018;9:77.

36. Park YW. Milk | Milks of other domesticated mammals (pigs, yaks, reindeer, etc.). In: Encyclopedia of Dairy Sciences. Elsevier; 2011. p. 530-7. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780123744074003198. [Last accessed on 17 Aug 2023].

37. Jenness R, Sloan RE. The composition of milks of varous species: a review. Dairy Sci Abstr 1970;32:599-612.

38. Kuhn NJ. The lactose and neuraminlactose content of rat milk and mammary tissue. Biochem J 1972;130:177-80.

39. Wojtas E, Zachwieja A, Piksa E, Zielak-Steciwko AE, Szumny A, Jarosz B. Effect of soy lecithin supplementation in beef cows before calving on colostrum composition and serum total protein and immunoglobulin G concentrations in calves. Animals 2020;10:765.

40. Ludwiczak A, Składanowska-Baryza J, Kuczyńska B, Stanisz M. Hycole doe milk properties and kit growth. Animals 2020;10:214.

41. Henrick BM, Rodriguez L, Lakshmikanth T, et al. Bifidobacteria-mediated immune system imprinting early in life. Cell 2021;184:3884-98.e11.

42. Laursen MF, Sakanaka M, von Burg N, et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol 2021;6:1367-82.

43. Sakurama H, Kiyohara M, Wada J, et al. Lacto-N-biosidase encoded by a novel gene of bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression. J Biol Chem 2013;288:25194-206.

44. Wada J, Ando T, Kiyohara M, et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 2008;74:3996-4004.

45. Katayama T, Sakuma A, Kimura T, et al. Molecular cloning and characterization of bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 2004;186:4885-93.

46. Sakurama H, Fushinobu S, Hidaka M, et al. 1,3-1,4-α-L-fucosynthase that specifically introduces Lewis a/x antigens into type-1/2 chains. J Biol Chem 2012;287:16709-19.

47. Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto K. An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 2011;21:437-47.

48. Moeller AH, Caro-Quintero A, Mjungu D, et al. Cospeciation of gut microbiota with hominids. Science 2016;353:380-2.

49. Goto K, Fukuda K, Senda A, et al. Chemical characterization of oligosaccharides in the milk of six species of new and old world monkeys. Glycoconj J 2010;27:703-15.

50. Bottacini F, Milani C, Turroni F, et al. Bifidobacterium asteroides PRL2011 genome analysis reveals clues for colonization of the insect gut. PLoS One 2012;7:e44229.

51. Zuo F, Marcotte H. Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing. Curr Opin Biotechnol 2021;70:75-82.

52. Gacesa R, Kurilshikov A, Vich Vila A, et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 2022;604:732-9.

Cite This Article

Export citation file: BibTeX | RIS

OAE Style

Murakami R, Yoshida K, Sakanaka M, Urashima T, Xiao JZ, Katayama T, Odamaki T. Preferential sugar utilization by bifidobacterial species. Microbiome Res Rep 2023;2:31. http://dx.doi.org/10.20517/mrr.2023.19

AMA Style

Murakami R, Yoshida K, Sakanaka M, Urashima T, Xiao JZ, Katayama T, Odamaki T. Preferential sugar utilization by bifidobacterial species. Microbiome Research Reports. 2023; 2(4): 31. http://dx.doi.org/10.20517/mrr.2023.19

Chicago/Turabian Style

Murakami, Ryuta, Keisuke Yoshida, Mikiyasu Sakanaka, Tadasu Urashima, Jin-Zhong Xiao, Takane Katayama, Toshitaka Odamaki. 2023. "Preferential sugar utilization by bifidobacterial species" Microbiome Research Reports. 2, no.4: 31. http://dx.doi.org/10.20517/mrr.2023.19

ACS Style

Murakami, R.; Yoshida K.; Sakanaka M.; Urashima T.; Xiao J.Z.; Katayama T.; Odamaki T. Preferential sugar utilization by bifidobacterial species. Microbiome. Res. Rep. 2023, 2, 31. http://dx.doi.org/10.20517/mrr.2023.19

About This Article

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Data & Comments

Data

Views
510
Downloads
85
Citations
0
Comments
0
2

Comments

Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.

0
Download PDF
Cite This Article 2 clicks
Like This Article 2 likes
Share This Article
Scan the QR code for reading!
See Updates
Contents
Figures
Related
Microbiome Research Reports
ISSN 2771-5965 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/